{
    "id": 2758,
    "fullName": "LRP1B loss",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "LRP1B loss indicates loss of the LRP1B gene, mRNA, and protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 53353,
        "geneSymbol": "LRP1B",
        "terms": [
            "LRP1B",
            "LRP-1B",
            "LRP-DIT",
            "LRPDIT"
        ]
    },
    "variant": "loss",
    "createDate": "12/17/2014",
    "updateDate": "09/19/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1473,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, loss of LRP1B was associated with acquired resistance to liposomal doxorubicin. Cell based assays indicated LRP1B likely played a role in endocytosis of the liposomally modified doxorubicin (PMID: 22896685).",
            "molecularProfile": {
                "id": 2576,
                "profileName": "LRP1B loss"
            },
            "therapy": {
                "id": 1008,
                "therapyName": "Pegylated liposomal-doxorubicin",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 1352,
                    "pubMedId": 22896685,
                    "title": "LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22896685"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2576,
            "profileName": "LRP1B loss",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}